XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net (loss) $ (34,945) $ 71,376
Adjustments to reconcile net (loss)/income to net cash provided by operating activities:    
Tax benefit from stock-based compensation 9,244 10,763
Depreciation and amortization 305 737
Loss on disposal of fixed assets 9,518 4,050
Impairment of intangibles (9,109) 2
Deferred taxes (16) (21)
Accrued interest on note receivable - related party 11,207 11,608
Marketable Securities, Realized Gain (Loss) 0 (5)
Changes, net of acquisitions, in:    
Accounts receivable 17,984 3,909
Factor accounts receivable 92,975 (43,832)
Notes receivable - related party 33,614 (8,873)
Repayment of Notes Receivable from Related Parties 204 204
Inventories (9,247) (7,849)
Prepaid expenses, prepaid taxes, deposits and other (76,183) 26,232
Increase (Decrease) in Employee Related Liabilities (8,812) (4,974)
Increase (Decrease) in Other Accrued Liabilities (4,259) (1,449)
Net cash provided by operating activities 57,867 59,761
Net benefit in connection with reversal of contingent liability partially offset by acceleration of amortization related to Kate Spade license termination 0 (1,868)
Provision for Doubtful Accounts 0 (259)
Cash flows from investing activities:    
Capital expenditures (4,320) (6,214)
Purchases of marketable securities (25,818) (37,426)
Repayment of notes receivable 25,656 69,488
Net cash (used in)/provided by investing activities (4,482) 25,848
Cash flows from financing activities:    
Proceeds from exercise of stock options (29,678) (51,156)
Payments of Dividends (12,459) (23,987)
Tax benefit from the exercise of options 960 1,799
Net cash provided by/(used in) financing activities 1,844 (73,174)
Effect of Exchange Rate on Cash and Cash Equivalents (1,229) 198
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests 359 1,283
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 0 (1,113)
Net increase in cash and cash equivalents 54,000 12,633
Cash and cash equivalents – beginning of period 264,101 200,031
Cash and cash equivalents – end of period 318,101 212,664
Tangible Asset Impairment Charges 12,012 0
Line of Credit Facility, Maximum Month-end Outstanding Amount 42,662 0
Repayments of Lines of Credit (134,122) 0
Line of Credit Assumed 176,784 0
Operating Lease, Impairment Loss 17,986 0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability $ 4,611 $ 0